Literature DB >> 31914800

HIV-1 Central Nervous System Compartmentalization and Cytokine Interplay in Non-Subtype B HIV-1 Infections in Nigeria and Malawi.

Olubusuyi Moses Adewumi1,2, Elena Dukhovlinova3, Nathan Y Shehu4, Shuntai Zhou3, Olivia D Council3,5, Maxwell O Akanbi4,6, Babafemi Taiwo7, Adesola Ogunniyi8, Kevin Robertson9, Cecilia Kanyama10, Mina C Hosseinipour10,11, Ronald Swanstrom3,5,12.   

Abstract

HIV-1 compartmentalization in the central nervous system (CNS) and its contribution to neurological disease have been well documented. Previous studies were conducted among people infected with subtypes B or C where CNS compartmentalization has been observed when comparing viral sequences in the blood to virus in cerebrospinal fluid (CSF). However, little is known about CNS compartmentalization in other HIV-1 subtypes. Using a deep sequencing approach with Primer ID, we conducted a cross-sectional study among Nigerian and Malawian HIV-1 cohorts with or without fungal Cryptococcus infection diagnosed as cryptococcal meningitis (CM) to determine the extent of CSF/CNS compartmentalization with CM. Paired plasma and CSF samples from 45 participants were also analyzed for cytokine/chemokine levels. Viral populations comparing virus in the blood and the CSF ranged from compartmentalized to equilibrated, including minor or partial compartmentalization or clonal amplification of a single viral sequence. The frequency of compartmentalized viral populations in the blood and CSF was similar between the CM- and CM+ participants. We confirmed the potential to see compartmentalization with subtype C infection and have also documented CNS compartmentalization of an HIV-1 subtype G infection. Cytokine profiles indicated a proinflammatory environment, especially within the CSF/CNS. However, sCD163 was suppressed in the CSF in the presence of CM, perhaps due to elevated levels of IL-4, which were also a feature of the cytokine profile, showing a distinct cytokine profile with CM.

Entities:  

Keywords:  CNS compartmentalization; HIV-1; cryptococcal meningitis; cytokine

Year:  2020        PMID: 31914800      PMCID: PMC7262640          DOI: 10.1089/AID.2019.0245

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  45 in total

1.  Individuals with HIV-1 Subtype C Infection and Cryptococcal Meningitis Exhibit Viral Genetic Intermixing of HIV-1 Between Plasma and Cerebrospinal Fluid and a High Prevalence of CXCR4-Using Variants.

Authors:  Katlego Sojane; Richard T Kangethe; Christina C Chang; Mahomed-Yunus S Moosa; Sharon R Lewin; Martyn A French; Thumbi Ndung'u
Journal:  AIDS Res Hum Retroviruses       Date:  2018-05-23       Impact factor: 2.205

2.  Primer ID Validates Template Sampling Depth and Greatly Reduces the Error Rate of Next-Generation Sequencing of HIV-1 Genomic RNA Populations.

Authors:  Shuntai Zhou; Corbin Jones; Piotr Mieczkowski; Ronald Swanstrom
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

3.  Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation.

Authors:  Viktor Dahl; Julia Peterson; Dietmar Fuchs; Magnus Gisslen; Sarah Palmer; Richard W Price
Journal:  AIDS       Date:  2014-09-24       Impact factor: 4.177

4.  Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.

Authors:  Michael J Peluso; Francesca Ferretti; Julia Peterson; Evelyn Lee; Dietmar Fuchs; Antonio Boschini; Magnus Gisslén; Nancy Angoff; Richard W Price; Paola Cinque; Serena Spudich
Journal:  AIDS       Date:  2012-09-10       Impact factor: 4.177

5.  Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing.

Authors:  Jesus F Salazar-Gonzalez; Elizabeth Bailes; Kimmy T Pham; Maria G Salazar; M Brad Guffey; Brandon F Keele; Cynthia A Derdeyn; Paul Farmer; Eric Hunter; Susan Allen; Olivier Manigart; Joseph Mulenga; Jeffrey A Anderson; Ronald Swanstrom; Barton F Haynes; Gayathri S Athreya; Bette T M Korber; Paul M Sharp; George M Shaw; Beatrice H Hahn
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

6.  Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.

Authors:  Síle F Molloy; Cecilia Kanyama; Robert S Heyderman; Angela Loyse; Charles Kouanfack; Duncan Chanda; Sayoki Mfinanga; Elvis Temfack; Shabir Lakhi; Sokoine Lesikari; Adrienne K Chan; Neil Stone; Newton Kalata; Natasha Karunaharan; Kate Gaskell; Mary Peirse; Jayne Ellis; Chimwemwe Chawinga; Sandrine Lontsi; Jean-Gilbert Ndong; Philip Bright; Duncan Lupiya; Tao Chen; John Bradley; Jack Adams; Charles van der Horst; Joep J van Oosterhout; Victor Sini; Yacouba N Mapoure; Peter Mwaba; Tihana Bicanic; David G Lalloo; Duolao Wang; Mina C Hosseinipour; Olivier Lortholary; Shabbar Jaffar; Thomas S Harrison
Journal:  N Engl J Med       Date:  2018-03-15       Impact factor: 91.245

7.  Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion.

Authors:  Elaine R Thomas; Rebecca L Dunfee; Jennifer Stanton; Derek Bogdan; Joann Taylor; Kevin Kunstman; Jeanne E Bell; Steven M Wolinsky; Dana Gabuzda
Journal:  Virology       Date:  2006-11-07       Impact factor: 3.616

Review 8.  Cryptococcal Meningitis and Anti-virulence Therapeutic Strategies.

Authors:  Kiem Vu; Javier A Garcia; Angie Gelli
Journal:  Front Microbiol       Date:  2019-02-26       Impact factor: 5.640

9.  The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis.

Authors:  Joseph N Jarvis; Joseph P Casazza; Hunter H Stone; Graeme Meintjes; Stephen D Lawn; Stuart M Levitz; Thomas S Harrison; Richard A Koup
Journal:  J Infect Dis       Date:  2013-03-14       Impact factor: 5.226

10.  Adaptive Immunity to Cryptococcus neoformans Infections.

Authors:  Liliane Mukaremera; Kirsten Nielsen
Journal:  J Fungi (Basel)       Date:  2017-11-21
View more
  4 in total

Review 1.  Neuroimmunology of CNS HIV Infection: A Narrative Review.

Authors:  Ana-Claire Meyer; Alfred Kongnyu Njamnshi; Magnus Gisslen; Richard W Price
Journal:  Front Neurol       Date:  2022-06-14       Impact factor: 4.086

2.  Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana.

Authors:  Nametso Kelentse; Sikhulile Moyo; Kesaobaka Molebatsi; Olorato Morerinyane; Shatho Bitsang; Ontlametse T Bareng; Kwana Lechiile; Tshepo B Leeme; David S Lawrence; Ishmael Kasvosve; Rosemary Musonda; Mosepele Mosepele; Thomas S Harrison; Joseph N Jarvis; Simani Gaseitsiwe
Journal:  Biomedicines       Date:  2022-06-13

3.  A preliminary study on the characteristics of Th1/Th2 immune response in cerebrospinal fluid of AIDS patients with cryptococcal meningitis.

Authors:  Aixin Li; Wenjiao Zhu; Jiming Yin; Xiaojie Huang; Lijun Sun; Wei Hua; Wen Wang; Tong Zhang; Lili Dai; Hao Wu
Journal:  BMC Infect Dis       Date:  2021-05-29       Impact factor: 3.090

4.  Primer ID Next-Generation Sequencing for the Analysis of a Broad Spectrum Antiviral Induced Transition Mutations and Errors Rates in a Coronavirus Genome.

Authors:  Shuntai Zhou; Collin S Hill; Michael U Clark; Timothy P Sheahan; Ralph Baric; Ronald Swanstrom
Journal:  Bio Protoc       Date:  2021-03-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.